Original Article | Published:

Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia

Oncogene volume 36, pages 50355044 (31 August 2017) | Download Citation

Abstract

Colorectal cancer (CRC) is characterized by genome-wide alterations to DNA methylation that influence gene expression and genomic stability. Less is known about the extent to which methylation is disrupted in the earliest stages of CRC development. In this study, we have combined laser-capture microdissection with reduced representation bisulfite sequencing to identify cancer-associated DNA methylation changes in human aberrant crypt foci (ACF), the earliest putative precursor to CRC. Using this approach, methylation profiles have been generated for 10 KRAS-mutant ACF and 10 CRCs harboring a KRAS mutation, as well as matched samples of normal mucosa. Of 811 differentially methylated regions (DMRs) identified in ACF, 537 (66%) were hypermethylated and 274 (34%) were hypomethylated. DMRs located within intergenic regions were heavily enriched for AP-1 transcription factor binding sites and were frequently hypomethylated. Furthermore, gene ontology analysis demonstrated that DMRs associated with promoters were enriched for genes involved in intestinal development, including homeobox genes and targets of the Polycomb repressive complex 2. Consistent with their role in the earliest stages of colonic neoplasia, 75% of the loci harboring methylation changes in ACF were also altered in CRC samples, though the magnitude of change at these sites was lesser in ACF. Although aberrant promoter methylation was associated with altered gene expression in CRC, this was not the case in ACF, suggesting the insufficiency of methylation changes to modulate gene expression in early colonic neoplasia. Altogether, these data demonstrate that DNA methylation changes, including significant hypermethylation, occur more frequently in early colonic neoplasia than previously believed, and identify epigenomic features of ACF that may provide new targets for cancer chemoprevention or lead to the development of new biomarkers for CRC risk.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    American Cancer Society.Cancer Facts & Figures 2016. American Cancer Society: Atlanta, GA, USA, 2016.

  2. 2.

    , . The epigenomics of cancer. Cell 2007; 128: 683–692.

  3. 3.

    . DNA hypomethylation in cancer cells. Epigenomics 2009; 1: 239–259.

  4. 4.

    , , , . Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455.

  5. 5.

    . CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21: 5427–5440.

  6. 6.

    , , . Accumulation of aberrant DNA methylation during colorectal cancer development. World J Gastroenterol 2014; 20: 978–987.

  7. 7.

    , , , , , et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 2006; 94: 593–598.

  8. 8.

    , , , . Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways. Cancer Prev Res 2012; 5: 374–384.

  9. 9.

    , . Field effect in cancer-an update. Ann Clin Lab Sci 2009; 39: 331–337.

  10. 10.

    , , , , , . Epigenetic alterations in RASSF1A in human aberrant crypt foci. Carcinogenesis 2006; 27: 1316–1322.

  11. 11.

    , , , , , . CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002; 160: 1823–1830.

  12. 12.

    , , , , , et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36: 417–422.

  13. 13.

    , , , , , et al. B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P. Br J Cancer 2015; 112: 403–412.

  14. 14.

    , , , , , et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787–793.

  15. 15.

    , , , , , et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 2007; 104: 18654–18659.

  16. 16.

    , , , , , et al. Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 2010; 16: 21–33.

  17. 17.

    , , , , , et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012; 22: 271–282.

  18. 18.

    , , , , , et al. Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma. Am J Pathol 2012; 180: 616–625.

  19. 19.

    , , , , , et al. The case for a pre-cancer genome atlas (PCGA). Cancer Prev Res 2016; 9: 119–124.

  20. 20.

    , , , , , . Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nat Protoc 2011; 6: 468–481.

  21. 21.

    , , , , , et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–15550.

  22. 22.

    , , , , . Apical constriction and invagination downstream of the canonical Wnt signaling pathway requires Rho1 and Myosin II. Dev Biol 2010; 340: 54–66.

  23. 23.

    , , . Targeted disruption of the homeobox transcription factor Nkx2-3 in mice results in postnatal lethality and abnormal development of small intestine and spleen. Development 1999; 126: 2215–2225.

  24. 24.

    , , , , , et al. Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development 2012; 139: 488–497.

  25. 25.

    , , . Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol 1999; 13: 1474–1486.

  26. 26.

    , , , , , et al. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 2006; 133: 833–843.

  27. 27.

    , , , . Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development 2000; 127: 3457–3466.

  28. 28.

    , , , , , et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499–507.

  29. 29.

    , . The polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343–349.

  30. 30.

    , , , , , et al. Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa. BMC Cancer 2011; 11: 450.

  31. 31.

    , , . HOX genes and their role in the development of human cancers. J Mol Med 2014; 92: 811–823.

  32. 32.

    , , , , , et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010; 38: 576–589.

  33. 33.

    , , , , , et al. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br J Cancer 2009; 101: 1282–1289.

  34. 34.

    , . Association of DNA methyltransferases expression with global and gene-specific DNA methylation in colorectal cancer cells. Cell Biochem Funct 2015; 33: 427–433.

  35. 35.

    , , , , , et al. Whole-genome methylation analysis of benign and malignant colorectal tumours. J Pathol 2013; 229: 697–704.

  36. 36.

    , , , , , et al. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol 2003; 162: 1361–1371.

  37. 37.

    , , , , , et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 2007; 67: 3551–3554.

  38. 38.

    , , , , , et al. Polycomb repressive complex 2 impedes intestinal cell terminal differentiation. J Cell Sci 2012; 125: 3454–3463.

  39. 39.

    , , , , , et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci USA 2007; 104: 5527–5532.

  40. 40.

    , , , , , et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39: 157–158.

  41. 41.

    , , , , , et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39: 237–242.

  42. 42.

    , , , , , et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39: 232–236.

  43. 43.

    , , , , , et al. Histone H3 lysine 27 trimethylation in adult differentiated colon associated to cancer DNA hypermethylation. Epigenetics 2009; 4: 107–113.

  44. 44.

    , , , , , et al. Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors. Cancer Res 2014; 74: 3617–3629.

  45. 45.

    , , , , , . The dynamic architecture of Hox gene clusters. Science 2011; 334: 222–225.

  46. 46.

    , , , . Epigenetic control of skull morphogenesis by histone deacetylase 8. Genes Dev 2009; 23: 1625–1630.

  47. 47.

    , , , , , et al. Expression of HOX homeobox genes in the adult human colonic mucosa (and colorectal cancer?). Int J Mol Med 2005; 16: 581–587.

  48. 48.

    , , , , , et al. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer 2008; 7: 94.

  49. 49.

    , , , , . Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 2009; 11: R14.

  50. 50.

    , . AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4: E131–E136.

  51. 51.

    , , , , , et al. AP-1 and colorectal cancer. Inflammopharmacology 2005; 13: 113–125.

  52. 52.

    , , . The regulatory mechanism of the LY6K gene expression in human breast cancer cells. J Biol Chem 2012; 287: 38889–38900.

  53. 53.

    , , , , , et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 2012; 44: 40–46.

  54. 54.

    , , , , , . HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci. Mol Cancer Res 2014; 12: 823–829.

  55. 55.

    , , , . Single base resolution analysis of 5-methylcytosine and 5-hydroxymethylcytosine by RRBS and TAB-RRBS. Methods Mol Biol 2015; 1238: 273–287.

  56. 56.

    , . COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997; 25: 2532–2534.

  57. 57.

    , , . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57.

Download references

Acknowledgements

This work was supported by NIH grant CA159976 to DWR, and NIH grants CA084469 and CA160965 to GPP.

Author information

Author notes

    • M P Hanley
    •  & M A Hahn

    These authors contributed equally to this work.

Affiliations

  1. Center for Molecular Medicine, School of Medicine, UConn Health, Farmington, CT, USA

    • M P Hanley
    •  & D W Rosenberg
  2. Department of Genetics and Genome Sciences, UConn Health, Farmington, CT, USA

    • M P Hanley
    •  & D W Rosenberg
  3. Department of Surgery, City of Hope, Duarte, CA, USA

    • M A Hahn
    • , A H Choi
    •  & Y Fong
  4. Department of Information Sciences, City of Hope, Duarte, CA, USA

    • A X Li
  5. Department of Molecular Medicine, Beckman Research Institute, City of Hope, Duarte, CA, USA

    • X Wu
  6. The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA

    • J Lin
    •  & Z Ouyang
  7. Integrative Genomics Core, Beckman Research Institute, City of Hope, Duarte, CA, USA

    • J Wang
  8. Institute for Systems Genomics, University of Connecticut, Farmington, CT, USA

    • Z Ouyang
  9. Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA

    • G P Pfeifer
  10. Division of Gastroenterology, School of Medicine, UConn Health, Farmington, CT, USA

    • T J Devers
  11. Colon Cancer Prevention Program, Neag Comprehensive Cancer Center, UConn Health, Farmington, CT, USA

    • D W Rosenberg

Authors

  1. Search for M P Hanley in:

  2. Search for M A Hahn in:

  3. Search for A X Li in:

  4. Search for X Wu in:

  5. Search for J Lin in:

  6. Search for J Wang in:

  7. Search for A H Choi in:

  8. Search for Z Ouyang in:

  9. Search for Y Fong in:

  10. Search for G P Pfeifer in:

  11. Search for T J Devers in:

  12. Search for D W Rosenberg in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to D W Rosenberg.

Supplementary information

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/onc.2017.130

Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)

Further reading Further reading